{
    "id": 31477,
    "fullName": "EGFR D770_N771insVDSVDNP",
    "impact": "insertion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "EGFR D770_N771insVDSVDNP results in the insertion of seven amino acids in the protein kinase domain of the Egfr protein between amino acids 770 and 771 (UniProt.org). D770_N771insVDSVDNP has not been biochemically characterized, but is predicted to lead to a gain of function based on the effect of other Egfr exon 20 insertions (PMID: 24353160).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 440,
                    "pubMedId": 24353160,
                    "title": "Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24353160"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "D770_N771insVDSVDNP",
    "createDate": "11/05/2019",
    "updateDate": "11/05/2019",
    "referenceTranscriptCoordinates": {
        "id": 185267,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55181319_55181320insGTAGACAGCGTAGACAACCCT",
        "cDna": "c.2310_2311insGTAGACAGCGTAGACAACCCT",
        "protein": "p.D770_N771insVDSVDNP",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19049,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Iressa (gefitinib) treatment resulted in immediate disease progression after 4 weeks of treatment in a patient with metastatic lung adenocarcinoma harboring EGFR D770_N771insVDSVDNP (PMID: 21841502).",
            "molecularProfile": {
                "id": 33829,
                "profileName": "EGFR D770_N771insVDSVDNP"
            },
            "therapy": {
                "id": 751,
                "therapyName": "Gefitinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 16690,
                    "pubMedId": 21841502,
                    "title": "Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21841502"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 33829,
            "profileName": "EGFR D770_N771insVDSVDNP",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 185267,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55181319_55181320insGTAGACAGCGTAGACAACCCT",
            "cDna": "c.2310_2311insGTAGACAGCGTAGACAACCCT",
            "protein": "p.D770_N771insVDSVDNP",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}